Due to their biodegradability, magnesium and magnesium based alloys could represent the third generation of biomaterials. However, their mechanical properties and time of degradation have to match application needs. Several approaches, such as choice of alloying elements or tailored microstructure, are employed to tailor corrosion behaviour. Due to the high electrochemical activity of Mg, numerous environmental factors (e.g., temperature and surrounding ion composition) are influencing its corrosion behaviour causing its unpredictability. Nevertheless, the need of reliable in vitro model(s) to predict in vivo implant degradation is increasing. In attempt to find a correlation between in vitro and vivo corrosion rates, this review presents a systematic literature survey as well as an attempt to correlate the different results.
Introduction
Mg and its alloys have been extensively investigated in recent decades due to several properties that make them promising candidates for biodegradable materials for medical applications. These materials exhibit biocompatibility and appropriate mechanical properties for use, for example, as orthopaedic implants [1] . Furthermore, Mg and Mg alloys can corrode completely under physiological conditions, avoiding the need for a second surgical intervention to remove the implant after bone healing. The great challenge here is to tailor the degradation in a manner that is suitable for a biological environment. Fast or uncontrolled corrosion is associated with strong hydrogen and ion release and severe pH changes, which can lead to undesirable biological reactions [2] . In parallel, a loss of mechanical stability before complete bone healing is observed. Therefore, the correct way of producing a Mg implant for orthopaedic applications remains under discussion [3] . One of the approaches employed to control corrosion behaviour is tailoring the composition and microstructure, including the grain size and texture of the base material. Such tailoring can be achieved by alloying or developing optimised manufacturing methods and post-processing techniques such as heat-treatment [4] [5] [6] and other strategies such as the development of porous structures or composites [7] [8] [9] [10] . Another approach is the use of surface coatings, which can also increase the biocompatibility of medical devices [11, 12] . In addition to these attempts to improve corrosion resistance, the fundamental problem remains: metallic corrosion is an electrochemical process that involves reduction and oxidation reactions. Similar to other metals, the corrosion resistance of magnesium (Mg) or Mg alloys is influenced by the surrounding environment; therefore, it is important to note that in vivo, the corrosion will be determined mainly by the place of implantation (and the corresponding body fluids flow and composition), whereas in vitro, the environmental conditions are defined mainly by the corrosion solution employed.
Furthermore, as corrosion is an electrochemical reaction, further influencing factors such as temperature alter its degradation kinetics. Due to the high electrochemical activity of Mg, the relative importance of some environmental factors is greatly amplified (e.g., the ion content in the surrounding fluids) [13] . Therefore, one of the most exigent problems concerning Mg and Mg alloys is the unpredictable corrosion behaviour in vivo, where numerous ions are present in body fluids (e.g., Na, K, Ca, Mg, HCO 3 , Cl, HPO 4 and SO 4 ) and make metallic corrosion very hard to predict or define [14] . Additionally, thus far, no correlation between in vitro and in vivo corrosion rates has been presented, which proves the need for (I) improved in vitro models that mimic as close as possible the in vivo conditions, (II) the identification of factors influencing corrosion rate in vitro that can help to predict in vivo degradation behaviour and (III) the identification of corrosion mechanisms in vivo. The latter is especially difficult to determine because the monitoring of degradation as well as physiological parameters in vivo and online is more or less impossible at the current stage. A substantial number of scientific publications regarding the degradation of Mg and its alloys have reported a large range of results due to the different materials, methods and experimental conditions selected. To the best of our knowledge there has not been a systematic approach or agreement on the experimental conditions to study Mg degradation that could bridge the gap between laboratory results and performance in a living organism. Instead, it has been concluded that it is impossible to compare these conditions to find consistent limits for prediction of the corrosion rate of Mg alloys in vivo, which are considered the only reliable data [15] . Still, to make the laboratory experiments meaningful and to avoid unnecessary animal experiments, at least some type of correlation should be defined or a recommendation should be given under which experimental conditions are best comparable. This review is a systematic literature survey that provides an overview of the existing results for in vitro and in vivo corrosion rates and aims to evaluate the existence or lack of correlation between the in vitro and in vivo corrosion behaviour of Mg and Mg alloys. In an attempt to quantify such a possible correlation, the corrosion factor, which describes the ration between the corrosion rate in vitro and the corresponding value obtained in vivo, was calculated. An exhaustive survey of parameters influencing the corrosion rate is not the focus of this review. For instance, the effect of alloying elements, heat treatments, processing and coatings (used in vivo and in vitro) will not be considered. Nevertheless, the effect of some selected parameters on the corrosion rate that is determined by the environment will be discussed: (1) the selection of the corrosion solution and (2) the implantation site.
Bibliographic selection of in vivo data
A complex bibliographic survey was necessary to select the information for comparison of the corrosion behaviour of the different Mg alloys. The starting point was collection of all the publications regarding the corrosion rate of Mg and Mg alloys for orthopaedic applications in vivo.
Of the 50 animal studies (since the first use in 1900 by Pyer [16] until today [17] ), 30 were not considered due to lack of quantitative information about the corrosion rate (or insufficient data to calculate the rate). This result already highlights one severe problem: the great variety of possible parameters that are monitored during in vivo trials but not necessarily the corrosion rate. The remaining publications contained information for approximately 23 different Mg alloys and pure Mg (PMg) ( Table 1 ). These alloys were implanted mainly in the femur or tibia of three animal models: rabbit, rat and guinea pig. In some cases, the implants were located intramedullary, while in other cases, the implant was only in contact with cortical bone. Implants were even located subcutaneously in some studies. We are well aware that the implantation site -whether surrounded by blood, soft or hard tissuesignificantly affects the corrosion rate. Nonetheless, when comparing the corrosion rates for one specific material, the rates are not very different or at least the differences cannot be attributed to the implant location (Table 1) .
Among all the aspects affecting the results obtained in vivo, Table 1 highlights two remarkable ones that appear to cause large variability: method and time period considered to measure the corrosion rate.
Methods used to calculate the corrosion rate in vivo
There are several available approaches to estimate the corrosion rate in vivo: via weight loss -which is strictly speaking not an in vivo method -or via volume loss. To calculate the weight loss, the implant must be removed from the implantation site (see Table 2 ). Recent studies commonly employed micro computed tomography (µCT) [18] [19] [20] , allowing the calculation of the implant volume changes. The reduction in implant volume obtained from 3D µCT images can be converted into a general corrosion rate using a modification of the weight loss method. For better resolution, µCT is also performed ex vivo after removing the implant and bone from the animal. However, with better instrumentation, it is now also possible to follow the degradation process in vivo [20] and to differentiate the corrosion layer and the degraded implant from the surrounding tissues. Some studies provided semi-quantitative or qualitative data [21] [22] [23] to evaluate in vivo corrosion (i.e., giving a score value from 0-4 depending on the degree of degradation), which were not included in this review.
Periods considered to measure the corrosion rate in vivo
The periods used to measure the corrosion rate in vivo vary from a few days to more than one year. Consequently, the determined in vivo corrosion rates exhibit a broad variability depending on the time at which the corrosion rate was detected. For example, the corrosion rates of ZX50 without and with a surface treatment were calculated from volume loss by µCT after 1, 2, 3, 4, 8 and 12 weeks [24] . Without surface treatment, during the first 4 weeks after implantation, the corrosion rate remained unchanged at 1.7 mm/year but exhibited almost a two-fold increase to 3 mm/year after 8 weeks and to 4 mm/year after 12 weeks. For the treated ZX50 alloy, the initial corrosion rate was much lower (0.25 mm/year) and increased gradually until a final corrosion rate of 6 mm/year was reached after 12 weeks. If we only considered the corrosion rate obtained after 3 weeks, both materials would have the same corrosion rate, but as deduced from the previous data, this analysis is not a true representation of the corrosion behaviour of these alloys (treated ZX50 was completely degraded after 12 weeks, while untreated ZX50 remained almost intact). Due to the variability depending on the time considered and to the fact that there are not common points for all the Mg alloys (some studies are longer than others), an overall corrosion rate in vivo was calculated for every material as the average of all the corrosion rates at different time points. The corresponding error bar considered the severe variations over time points. This estimation is only a very rough approach to reach comparability with in vitro results. However, these systematic problems were also observed for in vitro measurements which supports the need for unified test procedures.
Bibliographic selection of in vitro data
In a subsequent step, in vitro studies with the same alloys as identified from the in vivo experiments were selected ( Table 3) . As expected, the number of available publications was much higher, also implying a higher variability in experimental set-ups. For two novel alloys (ZEK100 and AX30) that were tested in vivo, information regarding the corrosion rate in vitro is not yet available in the literature [25] . Therefore, this work summarises the corrosion rates both in vitro and in vivo for 20 materials. We are aware that the technique used to determine the corrosion rate, the corrosion medium and various other parameters (e.g., temperature) affect the degradation of the material.
Methods used to calculate corrosion rates in vitro
Depending on the method employed to evaluate the corrosion rate in vitro (i.e., electrochemical tests, hydrogen evolution or mass/volume loss after immersion test), a large range of results for the same alloy can be achieved. The methods and corresponding equations used for in vitro testing are summarised in Table 2 . Evaluation of the mass/volume loss, pH monitoring or hydrogen evolution all require a low cost and are methods that are easily performed. Electrochemical tests are simple to perform, highly reproducible, and suitable for qualitative studies of corrosion and more commonly, for mechanistic studies of the corrosion behavior [26, 27] . Potentiodynamic polarization (PDP) is the most frequently used electrochemical technique for studying in vitro corrosion of Mg alloys [26, . Electrochemical impedance spectroscopy (EIS), is another technique that has been widely used for evaluating corrosion of biomaterials [30, 31, 33, 35, 38, 44-46, 48-54, 56-58, 60-62, 64, 66, 69-82] .
However, it is important to note that electrochemical tests must be performed during short testing times, leading to accelerating corrosion situations that do not simulate the true corrosion situation in vivo [27, 83] and limit the correlation with the corrosion rate obtained from the other methods after longer periods of time [26] . Furthermore, the mass or volume loss methods are more similar to the ones employed in vivo (previously discussed). As an example of the different results obtained using different in vitro methodologies, Table 4 lists the corrosion rate of Mg and three different alloys obtained in two studies [84, 85] . Thus, only the corrosion rates obtained via mass or volume loss, and hydrogen evolution were further considered for evaluating the correlation in vitro-in vivo. Nevertheless, corrosion rates obtained with electrochemical tests (previously converted to corrosion rates in mm/years by the authors), are also included in table 3. A deeper analysis about the limitations and benefits of this (and other) methods can be found in Kirkland et al., 2012 [83] . Table 4 also demonstrates the effect of calculating the corrosion rate by mass-loss measurements without removing the corrosion products [86] that can lead to a negative rate. The comparability of in vitro corrosion was difficult because the rates were provided in different units, as parts per million (ppm) of Mg ion released to the corrosion solution [85, 87] , mg/cm 2 day [18, 73, 88, 89] , and percentage of weight or volume loss [21, 84, [90] [91] [92] among others. In this study, the corrosion rates were then all converted to mm/year, as this unit is the most frequently used unit observed in the literature. However, when the corrosion rates were expressed as percentage of weight or volume loss, or even as remaining volume after test, the initial dimensions of the sample were necessary and sometimes missing. Therefore, these measurements were also discarded.
Periods considered to measure the corrosion rates in vitro
As mentioned above, the time at which the corrosion rate is determined is crucial and this is also true for in vitro measurements. Most of the studies considered corrosion rates as a constant; however, a more detailed time-dependent study can show that the corrosion rate is not linear over time due to, for example, the formation of a protective corrosion layer on the material surface [93, 94] . Furthermore, alloying elements can increase the complexity of the time-dependent corrosion behaviour. Time points from 10 hours [87] to 18 weeks [90] are presented in this review. Some materials exhibit a high initial corrosion rate that decreases with immersion time due to the gradual formation of a protective layer that can only be detected when considering several time point measurements. Such a non-monotonic behavior has been confirmed by AC impedance measurements and explained by the competition between formation of a Ca-containing film and degradation of the original film [95] . To illustrate the high variability of corrosion rates depending on the immersion time as an example, in two studies, the corrosion rate of AZ31 (high purity; commercial) was observed over 20 days (data shown in Table 3 ). The authors determined the corrosion rate after 1, 2, 5, 10, 15 and 20 days [96] or after 5 and 20 days [93] . In both publications, the corrosion rate decreased from day 5 to day 20 by approximately 0.3 mm/year. However, in the more detailed study, it was possible to determine a linear decrease, while linearity could not be confirmed in the second study. Notably, Yibin et al. calculated the corrosion rate of AZ31 up to 30 days (after 2, 5, 10, 20 and 30 days), which revealed an increase of the corrosion rate after 20 days and modified the overall estimation of the corrosion behaviour. Furthermore, the author stipulated that the corrosion rate of the alloy was 0.3 mm/year, which corresponds to the corrosion rate after 10 days of immersion test, while the average calculated (from the different time points) would be 0.75 mm/year. Although the differences in material processing in both studies should also be considered, it is easy to appreciate how different the information obtained from the corrosion rate can be, depending on the time-points considered.
As previously explained for in vivo corrosion rates, common time points for all the materials are missing among all the studies. To overcome this problem and to allow for data comparison, in this paper, the overall corrosion rate was calculated as the average of the corrosion rate obtained at different time points.
Correlation in vitro -in vivo:
After the complex selection process of data, the average corrosion rates of 19 Mg alloys and pure Mg are finally included in this paper (Table 5 ). An overview of the results is presented in Fig. 1 as the average corrosion rate ± standard error. Each point in the graph represents the average corrosion rate for one of the material, calculated from the corrosion rates at different time points and collected from different studies. In addition, different implantation sites and corrosion media were included in that average. We are aware that by combining all these various parameters, we are making systematic assumption. However, it appears surprising that the overall calculated corrosion rates exhibit relatively small variations from one material to another, mostly being less than 2 mm/year (apart from results from electrochemical tests, where as previously mentioned, an accelerated corrosion rate is induced) and rather homogeneous, which justifies our approach to some extent. As depicted in Fig. 1 , it can be observed that the corrosion rate in vivo is described by a smaller range of values than is the in vitro corrosion rate. In vivo, the corrosion rates range from 0 to 1.5 mm/year (except Mg6Zn: 2.3 mm/year), whereas in vitro, the corrosion rates, even if exhibiting more exceptions, range mainly from 0.1 to 2 mm/year. LANd442 exhibited the highest in vitro corrosion rate (8.8 mm/year); however, its corrosion was studied only in Seitz et al. [86] (in vitro in SBF). The corrosion rate of LAE442 (3.9 ± 1.5 mm/year) and Mg-1.34Ca-3Zn (4.5 mm/year) are also exceptions; however, it is important to note the high standard error associated with the LAE442 corrosion rate. For all the Mg and Mg alloys represented in this review (except Mg6Zn), the in vivo corrosion rates are lower than are the in vitro ones.
In an attempt to quantify the correlation between the in vitro -in vivo corrosion rates, the corrosion factor (cf) was calculated by dividing the overall corrosion rate in vitro by the overall corrosion rate in vivo (Eq. 1). In the calculation of the corrosion factor, error propagation was included. Because the in vitro corrosion rates were usually higher, the resulting corrosion factor was >1 in most of the cases. Fig. 2 demonstrates that most of the corrosion factors are contained in a small range, varying mainly from 1 to 4.9. These values indicate that the possible corrosion rate in vivo on average 1 -5 times lower than the corrosion rate obtained in vitro. As expected, some exceptions are observed: for Mg6Zn, the corrosion factor is lower than 1 (0.06).
Other exceptions are both HP-and LP-coated AZ91, which are nearly stable in vivo (corrosion rate of approximately 0). Therefore, the corresponding corrosion factors are not shown in Fig. 2 , as they are not relevant (105 and infinite, respectively, which is not representative of the real corrosion behaviour). LAE442 and LANd442, as expected from their high in vitro corrosion rate, also exhibited high corrosion factors (12.7 ± 9.1 and 31.8, respectively). The relatively close correlation between the in vitro and in vivo corrosion rate was not obvious from the initial literature survey, and it is immanent that a clustering of values even below 2.5 can be observed. Upon closer examination, this finding could be correlated to the solution that was used in the in vitro measurements.
Correlation of the corrosion factor with the in vitro corrosion solution
To find systematic correlations, we studied the corrosion factors with respect to the material, temperature during measurements, implantation site and corrosion medium. As expected, no correlation was observed for the material (results not shown). Here, the statistics were too poor because, in general, only one data set per material was available, and no systematic assessment of changes in the material properties due to different treatments was performed. For the same reason, a systematic comparison of the correlation between the microstructure and the deviations of the in vitro and in vivo corrosion rates was impossible. When evaluating the effect of the animal model or implantation side on the corrosion rate, no systematic deviation of the corrosion factor was detected (results not shown). It should be noted that not all the materials included in this review were tested with all the mediums; thus, only those materials that allowed the most complete data sets were considered. We did not consider measurements performed in NaCl solutions, which are the most widely used in vitro corrosion conditions. Here, the drawback is that so many different NaCl concentrations were used that the statistics were insufficient because of only one data point per condition. However, when the corrosion factors were grouped according to the corrosion media, EBSS, SBF, Hank´s solution, MEM, and MEM with the addition of BSA employed for in vitro tests, a correlation became visible (Fig. 3) . We observed that -apart from a few exceptions -the corrosion factors obtained for a specific corrosion solution were rather similar. For EBSS and SBF, the corrosion factors are below 3, while for MEM, the factors are higher and more in the range between 1.5 -3.5. The addition of proteins increased these values to a range between 4 and 7. Hank's solution resulted in very different corrosion factors; due to a lack of statistics, it is difficult to judge if a correlation can be observed.
These results indicate that upon using the correct corrosion solution (and considering most likely a few other factors such as temperature, CO 2 content or maybe flow), it should be possible to approach corrosion values in vitro that reliably predict the behaviour in vivo.
Discussion
This study demonstrates that the overall corrosion rate in vitro was in general higher than the corrosion rate obtained in vivo and that the corrosion factors are similar when considering some of the media used for in vitro assessment of the degradation. For most materials, the results obtained in vitro and in vivo are grouped in a much narrower range than initially expected. Why are corrosion rates measured in vitro and in vivo different even for the same material, and is there any opportunity to obtain a better correlation? We must address methodological and systematic deviation and a severe lack of knowledge. As noted, the measurement of corrosion rates can be performed using several methods, and the results are not necessarily comparable. We can observe the systematic problem that it can be difficult to distinguish in vivo between the metal, the corrosion layer and the surrounded tissue. Some software used to calculate the corrosion rate in vivo cannot precisely define these limits, generating a non-reliable corrosion rate [97] . Then, the temperatures used to determine the corrosion rate are usually not in the physiological range. The effect of temperature on the corrosion rate has been demonstrated in several publications in vitro [98] . Kirkland et al. [83] observed that with high-purity Mg, the corrosion rate measured at 37°C (simulated body temperature) was twice higher than that measured at 20°C (room temperature). Furthermore, these authors also demonstrated that with a temperature increase of only 3°C (from 37°C to 40°C), the corrosion rate was increased by approximately 50%, foretelling a potential risk of a too fast initial corrosion rate of the materials after implantation. One of the major obstacles for comparability is the use of synthetic corrosion solutions in vitro that simulate the in vivo environment [56, 85, 94, [99] [100] [101] . The compositions of some of the solutions used for in vitro tests are listed in Table 6 . The general opinion is that the corrosion solution should be as close as possible to physiological conditions. Therefore, a simple solution of chlorides does not represent the chemical environment that the material will find in the body. Thus, the use of more realistic media such as simulated body fluids (SBF), MEM, Dulbecco´s modified eagle medium (DMEM), Hank's solution, and artificial plasma (AP) to measure mass loss are widely used (e.g., Kirkland et al. [102] ). Our analysis revealed that especially Earle´s balanced salt solution (EBSS), MEM and SBF result in a relatively good correlation between in vitro and in vivo results. SBF has precisely the same carbonate content as blood plasma and a very similar amount of other inorganic ions. EBSS and MEM contain a slightly lower amount of carbonate ion and more notable differences for other ions such as Ca and Mg. In addition to the composition of the corrosion medium, the presence of a buffering system has a large effect on the corrosion rate, as it is important to keep the pH constant around the materials [32, 56, 103, 104] . Non-buffered solutions allow a pH increase towards the basic regime, which leads to passivation due to the formation of protective layers. Among the buffer systems available for testing in vitro corrosion of biomaterials, NaHCO 3 /CO 2 buffers are the most similar to the system found in vivo. It has been shown that the choice of a more -bio‖realistic buffer will give rise to a behavior of the corrosion layers (and therefore the corrosion behaviour) closer to the one observed in vivo [105] . Layers such as crystalline Mg(OH) 2 , amorphous phosphate-containing and amorphous carbonated (Mg-Ca)-phosphate layers (with poor protective properties) form in the presence of NaCl and NaCl + Ca, NaCl + PO 3 , SBF, respectively [106] . If the pH is maintained in the neutral regime -as occurs in vivo -the corrosion will not be stopped. Apart from the corrosion solution, new approaches are being investigated, leading in some cases to corrosion behaviours further from the behaviour observed in vivo: among others, the use of dynamic test conditions should mimic the in vivo environment even better. Nevertheless the results obtained with AZ31 under both static and dynamic conditions [44] indicate a higher corrosion rate under dynamic conditions (1.5 mm/year with dynamic tests and 0.3 mm/year in static tests), differing more from the results obtained in vivo (corrosion rate of less than 1 mm/year). Furthermore, the corrosion kinetics over time appear to be affected by the dynamic conditions: in static medium in vitro, the corrosion rate tends to decrease at the beginning (high corrosion resistance) and then to increase with time. This result may be due to the formation of a protective layer [95] . In dynamic fluid tests, the corrosion rate does not tend to decrease with time because the protective layer cannot be formed [93] . In addition, with the aim of better simulating in vivo conditions, Schinhammer et al. used gaseous CO2 in SBF to keep the pH constant, avoiding the need of a buffer. Nonetheless, the in vitro degradation rate of the alloy WZ21 (0.8 mm/year) was more than twice the corrosion rate obtained in vivo (0. 36 mm/year) [107] .
Why is a lower corrosion rate observed in vivo for most of the materials? One possible explanation is the lower concentration of chloride ions present in blood plasma (103 mM) [108] and bone (48.6-56.7 mM) [99] than in SBF (147.8 mM) and in other commonly used media [31] .
Organic components, such as proteins and amino acids, lead to different corrosion behaviours. Proteins and amino acids in biological fluids are hypothesised to form an absorbed layer on the surface of Mg alloys that can lead to different responses depending on the alloy composition [29, 53, 75] . Other studies propose that proteins are not adhering but interfere in a chemical manner by changing the density and composition of the corrosion layer as a whole [109] . In PMg and LAE442, the presence of proteins accelerates the corrosion rate, while in other cases, such as in AZ31, AZ91 and MgCa, their presence resulted in no effects or even a decrease in the corrosion rate. Another study demonstrated that the addition of bovine serum albumin (BSA) to MEM medium increases the corrosion rate of most of the tested alloys; however, for Mg1.34Ca3Zn, the effect was again a decrease [104] . This contradictory effect can be explained as follows. First, the corrosion rate decrease may be due to the protective layer formed between the metal and the surroundings [110] , which can inhibit the effect of a pH change and hinder the diffusion of ions [56] . In addition, the corrosion rate increase may be explained by the fact that proteins may complex metal cations and accelerate the dissolution of Mg alloys. It has even been suggested that proteins can remove the oxide layer [111, 112] formed on the surface of the materials. In summary, organic and inorganic components as well as buffers systems have a clear effect on the corrosion rate of Mg-based materials; however, the results obtained in vitro and in vivo are controversial mainly due to the interaction of several conditions that are highly variable from one case to another.
In addition, the physiological environment and the capacity of the body to adapt to changing environmental conditions is a severe reason for the differences.
One of the environmental factors affecting the corrosion rate in vivo is the anatomical location of the implant. Differences in the flow rates, water content of tissues or hydrogen diffusion coefficients in different animal models have already been noted [113] . However, our analysis revealed that when comparing averaged corrosion rates, the order of changes in the corrosion rate is negligible.
The instability of the in vivo corrosion layer has been suggested as another factor explaining the differences between in vivo/in vitro corrosion rates. Mg(OH) 2 is one of the main components observed in the corrosion layer and is not stable in aqueous solutions, especially not in chloride-containing environments [85, 114] . As a chemical reaction, the corrosion of the Mg alloy would cease when an equilibrated concentration of ions is reached in the surrounding fluid. However, under in vivo conditions, the electrolyte concentrations are subjected to homoeostasis, and equilibrium is never reached, leading to the complete material corrosion [115] . Additionally, local changes in electrochemical conditions could also be caused by locally passivated areas that are covered by newly formed bone, which have been observed by µCT. These locally different corrosive environments could cause local anodic and cathodic sites, which could in turn lead to an accelerated corrosion rate following the morphology of pitting corrosion [85] . Thus, another proposed reason for the lower corrosion rate obtained in vivo could rely on the response of the host tissue to the surgical procedure and the presence of the material itself (e.g., inflammation and foreign body reaction): an initial pH decrease directly after surgery can result in a short-term enhancement of the corrosion rate, with the consequent formation of a stable corrosion layer, which reduces the corrosion rate of the implants (as time goes on). Nevertheless, these physiological reactions will dynamically change over time and depend on the type of surrounding tissue, affecting not only the pH but other important parameters such as the ion concentration and temperature and subsequently the corrosion rate [116] . Another proposed reason (which remains tentative) is the suppression of micro-galvanic corrosion in vivo, possibly due to the encapsulation of the material by the surrounding tissues [117] .
In general, we must state that there is a lack of information about human physiology that leads to unexpected corrosion behaviours. It has been previously reported that even when the implantation location is the same and the alloy has the same composition, the results regarding corrosion rate and hydrogen production can differ. Witte et al. [94] reported that the intramedullary implantation of AZ91 Mg alloy into guinea pig femora resulted in gas formation, with bubbles appearing within one week of implantation and disappearing after two to three weeks. In contrast, Wong et al. [18] could not detect gas formation during the entire period of study. This example demonstrates how important it is to decide how in vivo studies should be performed, perhaps even down to the surgical technique employed.
Summary
The differences between corrosion behaviour in vitro and in vivo (even with the same material composition) can be attributed mainly to the difficulties in mimicking the complex physiological conditions in vitro.
Lack of information and the highly variable methodological procedures in previous studies are some of the factors that limit the comparison of the corrosion behaviour. Some of the in vivo studies focus only on qualitative aspects, while a quantitative study is missing. Furthermore, some of the studies in vitro and in vivo do not provide the corrosion rate or sufficient information to calculate this rate (for example, the alloy density or sample dimensions are missing). The use of some standardised methods or common protocols for measuring the corrosion rate as well as common time points and a more detailed explanation about all the parameters used during experimental corrosion rate evaluation are key factors to allow comparison between results obtained and to improve our understanding about the complex corrosion behaviour of Mg and Mg alloys both in vitro and in vivo. Perhaps a round robin laboratory approach would be very helpful for this aim. Nevertheless, from the data collected in this review, two main facts can be noted: the first one is that in addition to the high variability in experimental set-ups when considering the overall corrosion rates for all the materials (both in vitro and in vivo), the variability is not as large as could be expected. The corrosion rates in vivo are lower for all the alloys and PMg (apart from one exception), showing a in vitro-in vivo correlation. Furthermore, when calculating the in vitro-in vivo corrosion factor, a systematic ratio was detected that varies mainly from approximately 1 to 5 units, indicating a possible corrosion rate in vivo between 1 and 4 times lower than the corrosion rate in vitro. This range of values is even reduced when selecting the right medium for in vitro testing (a reduction towards 1-3 units), indicating the existence of a systematic correlation. This correlation is more obvious when using media that better mimic physiological conditions (such as SBF, EBSS or MEM). 
